Brain Monoamine Oxidase A Binding in Major Depressive Disorder: Relationship to Selective Serotonin Reuptake Inhibitor Treatment, Recovery, and Recurrence

A rating scale for depression

Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879

An overlap invariant entropy measure of 3D medical image alignment

Studholme, C., Hill, D., & Hawkes, D. J. (1999) · Pattern Recognition · doi:10.1016/s0031-3203(98)00091-0 · Cited by 2,167

Nonlinear spatial normalization using basis functions

Ashburner, J., & Friston, K. J. (1999) · Human Brain Mapping · doi:10.1002/(sici)1097-0193(1999)7:4 · Cited by 1,888

Global burden of depressive disorders in the year 2000

Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735

The neural basis of loss aversion in decision-making under risk

Tom, S. M., Fox, C. R., Trepel, C., & Poldrack, R. A. (2007) · Science · doi:10.1126/science.1134239 · Cited by 1,733

The therapeutic potential of monoamine oxidase inhibitors

Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,401

Three-Year Outcomes for Maintenance Therapies in Recurrent Depression

Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,294

MONOAMINE OXIDASE: From Genes to Behavior

Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,235

Multimodal image coregistration and partitioning--a unified framework.

Ashburner, J., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 1,051

Rivastigmine–Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases

Vicente-Zurdo, D., Brunetti, L., Piemontese, L., Guedes, B., Cardoso, S. M., Chavarria, D., Borges, F., Madrid, Y., Chaves, S., & Santos, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098312 · Cited by 13

Meta-Analysis of white matter diffusion tensor imaging alterations in borderline personality disorder

Kelleher-Unger, I., Tajchman, Z. J., Chittano, G., & Vilares, I. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111205 · Cited by 11

Modeling heritability of temperamental differences, stress reactivity, and risk for anxiety and depression: Relevance to research domain criteria (RDoC)

Clinton, S. M., Shupe, E. A., Glover, M. E., Unroe, K. A., McCoy, C. R., Cohen, J. L., & Kerman, I. A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15158 · Cited by 15

The Assay of Enzyme Activity by Positron Emission Tomography

Cumming, P. D., & Vasdev, N. (2012) · Neuromethods · doi:10.1007/7657_2012_53 · Cited by 11

The MAOA rs979605 Genetic Polymorphism Is Differentially Associated with Clinical Improvement Following Antidepressant Treatment between Male and Female Depressed Patients

Chappell, K., Colle, R., Bouligand, J., Trabado, S., Fève, B., Becquemont, L., Corruble, E., & Verstuyft, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010497 · Cited by 11

Molecular Imaging of Depressive Disorders

Ruhé, H. G., Visser, A. K. D., Frøkjær, V. G., Haarman, B. C. M., Klein, H. C., & Booij, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_5 · Cited by 11

Neurochemical Imaging and Depressive Behaviours

Meyer, J. H. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_219 · Cited by 12

Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo

Spies, M., Murgaš, M., Vraka, C., Philippe, C., Gryglewski, G., Nics, L., Balber, T., Baldinger, P., Hartmann, A. M., Rujescu, D., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02506-2 · Cited by 13

Chronic Social Stress and Ethanol Increase Expression of KLF11, a Cell Death Mediator, in Rat Brain

Duncan, J. W., Wang, N., Zhang, X., Johnson, S., Harris, S., Zheng, B., Zhang, Q., Rajkowska, G., Miguel-Hidalgo, J. J., Sittman, D. B., et al. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9524-1 · Cited by 10

No effect of oral tyrosine on total tyrosine levels in breast milk: implications for dietary supplementation in early postpartum

Dowlati, Y., Ravindran, A. V., Maheux, M., Steiner, M. S., Stewart, D. E., & Meyer, J. H. (2014) · Archives of Women s Mental Health · doi:10.1007/s00737-014-0441-8 · Cited by 10

A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson’s disease

Liu, W., Wang, Y., & Youdim, M. B. H. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.09 · Cited by 9

Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure

Matthews, B. A., Tong, J., Attwells, S., Xu, X. Y., Le, A., Kish, S. J., & Meyer, J. H. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.11.036 · Cited by 9

A Review of Antidepressant Effects and Mechanisms of Three Common Herbal Medicines: Panax ginseng, Bupleurum chinense, and Gastrodia elata

Mu, D., & Ma, Q. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221116164836 · Cited by 9

Subchronic glucocorticoids, glutathione depletion and a postpartum model elevate monoamine oxidase a activity in the prefrontal cortex of rats

Raitsin, S., Tong, J., Kish, S. J., Xu, X. Y., Magomedova, L., Cummins, C. L., Andreazza, A. C., Scola, G., Baker, G. B., & Meyer, J. H. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.032 · Cited by 9

Offline encoding impaired by epigenetic regulations of monoamines in the guided propagation model of autism

Béroule, D. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0477-1 · Cited by 8

Effect ofMAOADNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission Tomography

Handschuh, P. A., Murgaš, M., Vraka, C., Nics, L., Hartmann, A. M., Pjrek, E., Baldinger, P., Wadsak, W., Winkler, D., Hacker, M., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac085 · Cited by 6

Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine

Matveychuk, D., Nunes, E. A., Ullah, N., Aldawsari, F. S., Velázquez‐Martínez, C. A., & Baker, G. B. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.011 · Cited by 6

M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus

Lam, C. S., Tipoe, G. L., Wong, J. K.-C., Youdim, M. B. H., & Fung, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166966 · Cited by 6

Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers

Fišar, Z. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_6 · Cited by 7

Monoamine Oxidase A and Serotonin Transporter Imaging with Positron Emission Tomography

Meyer, J. H. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_25 · Cited by 6

Uritica dioica improves brain dysfunctions in propionic acid autistic like rat model through brain monoamines and mitochondrial energy

Ali, E. H. A., Hassan, M. K., Abbas, O., E.Elmalahy, H., & Almaaty, A. A. (2020) · African Journal of Biological Sciences · doi:10.21608/ajbs.2020.133010 · Cited by 6

mRNA Levels of MAOA and 5-HT2A Receptor in Patients With Pathological Internet Use: Correlations With Comorbid Symptoms

Qiu, M., Zhang, C., Dai, Y., Zhang, L., Wang, Y., Peng, W., Chen, Y., Wen, C., Li, H., & Zhu, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.667699 · Cited by 5

Bacillus amyloliquefaciens SC06 attenuated high-fat diet induced anxiety-like behavior and social withdrawal of male mice by improving antioxidant capacity, intestinal barrier function and modulating intestinal dysbiosis

Wang, Y., Wang, B., Zeng, Z., Liu, R., Tang, L., Meng, X., & Li, W. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114172 · Cited by 5

Selegiline transdermal system in major depressive disorder

Patkar, A. A., Portland, K. B., & Pae, C. (2012) · Neuropsychiatry · doi:10.2217/npy.12.9 · Cited by 5

The levels of monoamines and their metabolites in the brain structures of rats with an experimental anxiodepressive state induced by administration of an inhibitor of dipeptidyl peptidase 4 in the early postnatal period

Kushnareva, E. Y., Krupina, N. A., Khlebnikova, N. N., Кудрин, В. С., Золотов, Н. Н., & Крыжановский, Г. Н. (2012) · Neurochemical Journal · doi:10.1134/s1819712412010047 · Cited by 5

Recent Research Progress on the Antidepressant-like Effect and Neuropharmacological Potential of Gastrodia elata Blume

Lin, Y., Lu, K., & Sheen, L. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0137-2 · Cited by 5

Inhibition of monoamine oxidase attenuates social defeat-induced memory impairment in goldfish, (Carassius auratus): A possible involvement of synaptic proteins and BDNF

Thangaleela, S., Varman, D. R., Sivasangari, K., & Rajan, K. E. (2020) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2020.108873 · Cited by 4

Neurotransmission in Mood Disorders

Fiar, Z., Hroudov, J., & Raboch, J. (2012) · InTech eBooks · doi:10.5772/31831 · Cited by 4

Protective Influence ofPhyllanthus Muellarianuson Ciprofloxacin-Induced Neurotoxicity in Male Rats

Ibitoye, O. B., Aliyu, N. O., & Ajiboye, T. O. (2019) · Journal of Dietary Supplements · doi:10.1080/19390211.2019.1586805 · Cited by 4

Molecular Imaging of Depressive Disorders

Ruhé, H. G., Frøkjær, V. G., Haarman, B. C. M., Jacobs, G. E., & Booij, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_4 · Cited by 3

Protamine cleavage specificity of the avian pathogen Escherichia coli OmpT reveals two substrate-binding sites related to virulence

Liu, J., Jiang, L., Wang, H., Wu, J., Gao, Q., Huan, C., & Gao, S. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1410113 · Cited by 3

Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease

Pandey, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_11 · Cited by 3

Biomarkers of Depression: Potential Diagnostic Tools

Perković, M. N., Erjavec, G. N., Štrac, D. Š., & Pivac, N. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_3 · Cited by 3

Depressed mood induction in early cigarette withdrawal is unaffected by acute monoamine precursor supplementation

Dowlati, Y., de Jesus, D. R., Selby, P. L., Fan, I., & Meyer, J. H. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s172334 · Cited by 3

fMRI and Other Neuroimaging Methods

Roy, A. K., Ferrara, E., Keesey, R., & Davis, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00215-6 · Cited by 3

Brain Arachidonic Acid Incorporation and Turnover are not Altered in the Flinders Sensitive Line Rat Model of Human Depression

Blanchard, H. C., Chang, L., Rezvani, A. H., Rapoport, S. I., & Taha, A. Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1719-6 · Cited by 3

Molecular neuroimaging of the serotonergic system with Positron Emission Tomography

Silberbauer, L., James, G. M., Spies, M., Michenthaler, P., Kranz, G., Kasper, S., & Lanzenberger, R. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00009-8 · Cited by 2

Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOI

BURCH, D. J., Asgharnejad, M., Gerson, W. A., Fielding, R. M., & Azzaro, A. J. (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.61 · Cited by 3

Dépression résistante : les autres stratégies thérapeutiques

Saba, G., Nieto, I., Bation, R., Allaïli, N., Bennabi, D., Molière, F., Richieri, R. M., Holtzmann, J., Bubrovszky, M., Camus, V., et al. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.02.005 · Cited by 3

Novel Phenotypes Detectable with PET in Mood Disorders

Meyer, J. H. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.02.008 · Cited by 3

Contribution of serotonergic and nitrergic pathways, as well as monoamine oxidase-a and Na+, K+-ATPase enzymes in antidepressant-like action of ((4-tert-butylcyclohexylidene) methyl) (4-methoxystyryl) sulfide (BMMS)

de Oliveira, R. L., Voss, G. T., Paltian, J. J., Pinz, M. P., Torres, M. L. C. P., Moreira, M. P., Dilelio, M. C., Silveira, C. C., Wilhelm, E. A., & Luchese, C. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00436-x · Cited by 3

Serotonin Receptors and Antidepressants: Neuroimaging Findings from Preclinical and Clinical Research

Handschuh, P. A., Konadu, M. E., Spurny‐Dworak, B., Silberbauer, L., Murgaš, M., & Lanzenberger, R. R. (2022) · Neuromethods · doi:10.1007/978-1-0716-2083-0_18 · Cited by 2

Trajectories of late-life depression: insights from molecular imaging

Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2

Monoamine Oxidase A and Serotonin Transporter Imaging with Positron Emission Tomography

Meyer, J. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_26 · Cited by 2

Monoamine Oxidase Inhibitors in Depressive Disorders

Meyer, J. H., Matveychuk, D., Holt, A., Santhirakumar, A., & Baker, G. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_98 · Cited by 2

Screening In silico Antidepressant Activity of Aqueous Extract of Leaves of Rumex acetosa L.

Shareef, M. M., & Bhavya, E. (2023) · Trends in Sciences · doi:10.48048/tis.2023.4664 · Cited by 2

The effects of imipramine and the inhibitor of prolylendopeptidase benzyloxycarbonyl-methionyl-2(S)-cyanopyrrolidine on the levels of monoamines and their metabolites in the brain of rats with an experimental anxious-depressive state

Khlebnikova, N. N., Kushnareva, E. Y., Кудрин, В. С., & Krupina, N. A. (2014) · Neurochemical Journal · doi:10.1134/s1819712414040059 · Cited by 2

Novel properties of the multifaceted drug phenelzine and its metabolite β-phenylethylidenehydrazine

Matveychuk, D. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3ft8dq4h · Cited by 2

Tilianin obtained from Agastache mexicana inhibits monoamine oxidase and modifies depressive behavior in rats

Rodríguez-Wilson, E., Estrada-Soto, S. E., Rubio‐Osornio, M., Tristán-López, L. A., Navarrete‐Vázquez, G., Gutiérrez-Hernández, A., & Montes, S. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae117 · Cited by 1

Ätiopathogenetische Beiträge der Bildgebungsforschung in der Psychiatrie

Falkai, P., Schneider, F. W., Gründer, G., & Kambeitz, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_7 · Cited by 1

Nutritional Therapies, Exercise, and Diet for Mental Disorders

Chakrabarty, K., & Chakrabarty, A. S. (2019) · Springer eBooks · doi:10.1007/978-981-15-0962-9_10 · Cited by 1

Depression

Guinjoan, S., & Nemeroff, C. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00119-6 · Cited by 1

The promise of biomarkers and response prediction

McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.028

Challenges for PET Neuroimaging of Depressive Disorders

Donald, & Philip, W. J. B. (2010) · Sciyo eBooks · doi:10.5772/9881

Ätiopathogenetische Beiträge der Bildgebungsforschung

Falkai, P., Schneider, F. W., & Gründer, G. (2007) · Springer eBooks · doi:10.1007/978-3-540-33129-2_6

4 – Approches pharmacologique et physiopathologique de la dépression majeure : un aller-retour paradigmatique

Gouzien, C., Doumy, O., & Aouizerate, B. (2015) · doi:10.1016/b978-2-294-73908-8.00004-5

P.1.e.005 Neural correlates of postpartum depression: elevated monoamine oxidase A (MAO-A) binding in prefrontal and anterior cingulate cortex

Sacher, J., Wilson, A. A., Houle, S., Romano, L., Hamidi, J., Rusjan, P., Rekkas, P. V., Stewart, D. E., & Meyer, J. H. (2012) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(12)70280-8

Review Article PET radiopharmaceuticals for probing enzymes in the brain

Holland, J. P., Cumming, P. D., & Vasdev, N. (2013)

Translational PET Imaging Research in Psychiatry

Hargreaves, R. J., & Rabiner, E. A. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00558

Molecular Imaging of Mood Episodes

Meyer, J. H. (2012) · Neuromethods · doi:10.1007/7657_2012_49

Article Open Access

Lawford‐Smith, H. (2015)

Impact of Medications Used in the Treatment of Mood Disorders on Monoaminergic Systems

Ghanbari, R. (2011) · Library and Archives Canada (Government of Canada) · doi:10.20381/ruor-4467

The effect of early–life exposure of rats to venlafaxine on behaviour and neurological markers of antidepressant action in adulthood

Kruger, R. (2014) · Boloka Institutional Repository (North-west University)

Psychiatric Disorders

Schatzberg, A. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00028-4

Development and Preclinical Evaulation of Novel Enzyme-targeting Radiotracers for Positron Emission Tomography

Hicks, J. W. (2015) · TSpace (University of Toronto)

Monoamine Oxidase A in Relation to Subtypes and Treatment of Major Depressive Disorder

Chiuccariello, L. (2015) · TSpace (University of Toronto)

Monoamine Oxidase-A in Borderline Personality Disorder and Antisocial Personality Disorder

Kolla, N. J. (2015) · TSpace (University of Toronto)

The Relationship of Alcohol Dependence to Monoamine Oxidase A

Matthews, B. A. (2015) · TSpace (University of Toronto)

The crucial role of reelin in a preclinical model of depression

Allen, J. E. (2017) · University Library - University of Saskatchewan (University of Saskatchewan)

Mental health and alcohol use disorder (AUD) comorbidity

Singh, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819680-9.00003-2

Influences On Monoamine Oxidase Activity In The Brain And Translation Into Major Depressive Disorder

Raitsin, S. (2018) · TSpace (University of Toronto)

Monoamine Oxidase Inhibitors in Depressive Disorders

Meyer, J. H., Matveychuk, D., Holt, A., Santhirakumar, A., & Baker, G. B. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_98-1

Ätiopathogenetische Beiträge der Bildgebungsforschung

Falkai, P., Schneider, F. W., & Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_7

Effect of MAOA DNA methylation on human in vivo protein expression measured by [ 11 C]harmine PET in healthy and depressed individualsPreprint

Handschuh, P. A., Murgaš, M., Vraka, C., Nics, L., Hartmann, A. M., Pjrek, E., Baldinger, P., Wadsak, W., Winkler, D., Hacker, M., et al. (2022) · medRxiv · doi:10.1101/2022.03.29.22273110

Ätiopathogenetische Beiträge der Bildgebungsforschung in der Psychiatrie

Falkai, P., Schneider, F. W., Gründer, G., & Kambeitz, J. P. (2017) · Springer eBooks · doi:10.1007/978-3-642-45028-0_7-2

Ätiopathogenetische Beiträge der Bildgebungsforschung in der Psychiatrie

Falkai, P., Schneider, F. W., Gründer, G., & Kambeitz, J. P. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_7-1

Research Applications of Positron Emission Tomography/Magnetic Resonance (PET/MR) Imaging in Depression

Xia, M., He, J., Xu, J., Fang, J., & Yong He, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-9902-4_14

Chapter 10. Monoamine Oxidase Inhibitors

Krishnan, K. R. R. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as10 · Cited by 1

A human-derived Bacteroides strain attenuates depressive-like behavior in a rat model of social defeat-induced stress

Dothard, M. I., Caboni, M., Norment, D., Sigmund, N., Allard, S. M., Gilbert, J. A., Gavrish, E., Al‐Ghalith, G. A., Der‐Avakian, A., & Strandwitz, P. (2026) · BMC Medicine · doi:10.1186/s12916-026-04787-y

Résistance à l’Insuline du Système Sérotoninergique : Implication dans les Troubles de l’Humeur Comorbides au Diabete De Type 2

Martin, H. (2021) · theses.fr (ABES) · doi:10.70675/63526938z3197z4632za668z0b62aa1e8cb8

A Mitochondria-Targeted AIE-ESIPT Fluorescent Probe for Imaging Monoamine Oxidase A Dynamics in Depression Models

Wang, X., Zhang, X., Zhao, X., Ding, Q., Che, F., Zhang, W., Li, Z., & Li, P. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c03441

Could chronic estradiol deficiency contribute to suicide risk in anorexia nervosa?

Mousa, A. M., McNeil, M., Mohamed, M. M. A., & Mahmoud, M. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100843

Elevated Monoamine Oxidase A Levels in the Brain: An Explanation for the Monoamine Imbalance of Major Depression

Meyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585

Brain Serotonin 1A Receptor Binding as a Predictor of Treatment Outcome in Major Depressive Disorder

Miller, J. M., Hesselgrave, N., Ogden, R. T., Zanderigo, F., Oquendo, M. A., Mann, J. J., & Parsey, R. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.021 · Cited by 96

Monoamine Oxidase A in Relation to Subtypes and Treatment of Major Depressive Disorder

Chiuccariello, L. (2015) · TSpace (University of Toronto)

Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms

Chiuccariello, L., Houle, S., Miler, L., Cooke, R. G., Rusjan, P., Rajkowska, G., Levitan, R. D., Kish, S. J., Kolla, N. J., Ou, X., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.297 · Cited by 78

Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder

Moriguchi, S., Wilson, A. A., Miler, L., Rusjan, P., Vasdev, N., Kish, S. J., Rajkowska, G., Wang, J., Bagby, M. R., Mizrahi, R., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0044 · Cited by 102